See also this year's filing and all EDGAR filings for this company.
PDF Report 0001340652_2022_Chemocentryx_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001340652, Chemocentryx Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 269,177,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 32,269,000 |
| 3 | remainder_Assets | 124,206,000 |
| 4 | LiabilitiesCurrent | 63,017,000 |
| 5 | LiabilitiesNoncurrent | 51,743,000 |
| 6 | remainder_Liabilities | 24,772,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 262,114,202 |
| 9 | ResearchAndDevelopmentExpense | 84,448,354 |
| 10 | remainder_Expenses | 198,186 |
| 11 | remainder_Revenues | 41,100,413 |
| 12 | remainder_NetIncome | -3,038,630 |
| 13 | remainder_ComprehensiveNetIncome | -534,089 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 425,652,000 |
| 1 | Liabilities | 139,532,000 |
| 2 | Expenses | 346,760,742 |
| 3 | Revenues | 41,100,413 |
| 4 | StockholdersEquity | 286,120,000 |
| 5 | NetIncome | -308,698,959 |
| 6 | ComprehensiveNetIncome | -308,966,004 |
| 7 | BaseVar | 478,308,937 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.11 |
| 9 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
